Catherine Lévy

7.3k total citations · 4 hit papers
22 papers, 4.4k citations indexed

About

Catherine Lévy is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Catherine Lévy has authored 22 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in Catherine Lévy's work include Cancer Immunotherapy and Biomarkers (10 papers), Immunotherapy and Immune Responses (7 papers) and T-cell and B-cell Immunology (6 papers). Catherine Lévy is often cited by papers focused on Cancer Immunotherapy and Biomarkers (10 papers), Immunotherapy and Immune Responses (7 papers) and T-cell and B-cell Immunology (6 papers). Catherine Lévy collaborates with scholars based in United States, Germany and France. Catherine Lévy's co-authors include Steven A. Rosenberg, Richard M. Sherry, Udai S. Kammula, Richard E. Royal, Marybeth S. Hughes, Suzanne L. Topalian, James Chih‐Hsin Yang, Donald E. White, Sharon Mavroukakis and Israel Lowy and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Neuroscience and The Journal of Immunology.

In The Last Decade

Catherine Lévy

19 papers receiving 4.4k citations

Hit Papers

Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) fo... 2005 2026 2012 2019 2010 2005 2007 2007 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma
    2010 954 citations Richard E. Royal, Catherine Lévy et al. Journal of Immunotherapy profile →
  2. Autoimmunity Correlates With Tumor Regression in Patients With Metastatic Melanoma Treated With Anti–Cytotoxic T-Lymphocyte Antigen-4
    2005 771 citations Peter Attia, Giao Q. Phan et al. Journal of Clinical Oncology profile →
  3. Ipilimumab (Anti-CTLA4 Antibody) Causes Regression of Metastatic Renal Cell Cancer Associated With Enteritis and Hypophysitis
    2007 537 citations James Chih‐Hsin Yang, Marybeth S. Hughes et al. Journal of Immunotherapy profile →
  4. Prognostic Factors Related to Clinical Response in Patients with Metastatic Melanoma Treated by CTL-Associated Antigen-4 Blockade
    2007 519 citations Jacob A. Klapper, Franz O. Smith et al. Clinical Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Catherine Lévy United States 12 3.7k 2.4k 769 496 319 22 4.4k
Tracee L. McMiller United States 13 4.2k 1.2× 2.6k 1.1× 841 1.1× 1.1k 2.1× 200 0.6× 26 5.1k
Arabella Young United States 23 2.6k 0.7× 2.0k 0.8× 1.1k 1.4× 535 1.1× 375 1.2× 47 4.4k
Yuru Meng United States 15 3.0k 0.8× 2.7k 1.1× 856 1.1× 654 1.3× 131 0.4× 18 4.4k
Ursina Teitelbaum United States 19 1.9k 0.5× 1.2k 0.5× 596 0.8× 279 0.6× 352 1.1× 54 2.7k
Elizabeth Stankevich United States 15 2.4k 0.7× 1.3k 0.5× 416 0.5× 665 1.3× 337 1.1× 39 2.9k
Geoffrey D. Young United States 12 2.3k 0.6× 1.4k 0.6× 740 1.0× 508 1.0× 169 0.5× 29 3.1k
Kazuaki Chikamatsu Japan 29 1.7k 0.5× 1.1k 0.5× 865 1.1× 428 0.9× 183 0.6× 152 3.0k
Philip Z. Brohawn United States 28 1.0k 0.3× 2.0k 0.8× 798 1.0× 425 0.9× 449 1.4× 64 4.1k
Eva Karamitopoulou Switzerland 40 2.1k 0.6× 702 0.3× 1.3k 1.6× 624 1.3× 339 1.1× 99 3.9k
Ester Fonsatti Italy 28 1.5k 0.4× 974 0.4× 1.7k 2.2× 704 1.4× 108 0.3× 64 3.3k

Countries citing papers authored by Catherine Lévy

Since Specialization
Citations

This map shows the geographic impact of Catherine Lévy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Lévy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Lévy more than expected).

Fields of papers citing papers by Catherine Lévy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Lévy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Lévy. The network helps show where Catherine Lévy may publish in the future.

Co-authorship network of co-authors of Catherine Lévy

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Lévy. A scholar is included among the top collaborators of Catherine Lévy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Lévy. Catherine Lévy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lévy, Catherine, et al.. (2025). Red Light Sensitivity of Non-image and Image Forming Visual Systems of Laboratory Rodents: Circadian Disruption and Behavioral Detection. Journal of Neuroscience. 45(20). e0157252025–e0157252025. 1 indexed citations
2.
Levis, S, Casey E. O’Neill, Catherine Lévy, et al.. (2023). Toll-like receptor 4 antagonists reduce cocaine-primed reinstatement of drug seeking. Psychopharmacology. 240(7). 1587–1600. 3 indexed citations
3.
Graves, Gary R., et al.. (2015). History of the Spotted Rail ( Pardirallus maculatus ) in Jamaica with first photographic documentation of breeding. Journal of Caribbean Ornithology. 28. 11–14.
4.
Prieto, Peter A., James Chih‐Hsin Yang, Richard M. Sherry, et al.. (2012). CTLA-4 Blockade with Ipilimumab: Long-term Follow-up of 177 Patients with Metastatic Melanoma. Clinical Cancer Research. 18(7). 2039–2047. 369 indexed citations
5.
Royal, Richard E., Catherine Lévy, Keli Turner, et al.. (2010). Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma. Journal of Immunotherapy. 33(8). 828–833. 954 indexed citations breakdown →
6.
Prieto, Peter A., Jin‐Hao Yang, Richard M. Sherry, et al.. (2010). Cytotoxic T lymphocyte-associated antigen 4 blockade with ipilimumab: Long-term follow-up of 179 patients with metastatic melanoma.. Journal of Clinical Oncology. 28(15_suppl). 8544–8544. 17 indexed citations
7.
Smith, Franz O., Jacob A. Klapper, James C. Yang, et al.. (2008). Treatment of Metastatic Melanoma Using Interleukin-2 Alone or in Conjunction with Vaccines. Clinical Cancer Research. 14(17). 5610–5618. 178 indexed citations
8.
Powell, Daniel J., Aloísio Felipe-Silva, Maria J. Merino, et al.. (2007). Administration of a CD25-Directed Immunotoxin, LMB-2, to Patients with Metastatic Melanoma Induces a Selective Partial Reduction in Regulatory T Cells In Vivo. The Journal of Immunology. 179(7). 4919–4928. 139 indexed citations
9.
Yang, James Chih‐Hsin, Marybeth S. Hughes, Udai S. Kammula, et al.. (2007). Ipilimumab (Anti-CTLA4 Antibody) Causes Regression of Metastatic Renal Cell Cancer Associated With Enteritis and Hypophysitis. Journal of Immunotherapy. 30(8). 825–830. 537 indexed citations breakdown →
10.
Klapper, Jacob A., Franz O. Smith, James Chih‐Hsin Yang, et al.. (2007). Prognostic Factors Related to Clinical Response in Patients with Metastatic Melanoma Treated by CTL-Associated Antigen-4 Blockade. Clinical Cancer Research. 13(22). 6681–6688. 519 indexed citations breakdown →
11.
Maker, Ajay V., James Chih‐Hsin Yang, Richard M. Sherry, et al.. (2006). Intrapatient Dose Escalation of Anti–CTLA-4 Antibody in Patients With Metastatic Melanoma. Journal of Immunotherapy. 29(4). 455–463. 214 indexed citations
12.
Blansfield, Joseph, James Chih‐Hsin Yang, Marybeth S. Hughes, et al.. (2005). Cytotoxic T-Lymphocyte-Associated Antigen-4 Blockage Can Induce Autoimmune Hypophysitis in Patients With Metastatic Melanoma and Renal Cancer. Journal of Immunotherapy. 28(6). 593–598. 276 indexed citations
13.
Maker, Ajay V., Giao Q. Phan, Peter Attia, et al.. (2005). Tumor Regression and Autoimmunity in Patients Treated With Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Interleukin 2: A Phase I/II Study. Annals of Surgical Oncology. 12(12). 1005–1016. 380 indexed citations
14.
Eskandari, Farideh, Sejal Mistry, Pedro E. Martinez, et al.. (2005). Younger, premenopausal women with major depressive disorder have more abdominal fat and increased serum levels of prothrombotic factors: implications for greater cardiovascular risk. Metabolism. 54(7). 918–924. 64 indexed citations
15.
Attia, Peter, Giao Q. Phan, Ajay V. Maker, et al.. (2005). Autoimmunity Correlates With Tumor Regression in Patients With Metastatic Melanoma Treated With Anti–Cytotoxic T-Lymphocyte Antigen-4. Journal of Clinical Oncology. 23(25). 6043–6053. 771 indexed citations breakdown →
16.
Lévy, Catherine. (2003). Vivre au minimum : enquête dans l'Europe de la précarité. 3 indexed citations
17.
Azorin, Jean‐Michel, et al.. (1990). Plasma Levels of 3-Methoxy-4-Hydroxyphenylglycol in Depressed Patients Compared with Normal Controls. Neuropsychobiology. 23(1). 18–24. 9 indexed citations
18.
Lévy, Catherine, et al.. (1984). Gewerkschaftskrise und Unternehmeroffensive in Frankreich. PROKLA Zeitschrift für kritische Sozialwissenschaft. 14(54). 106–130. 1 indexed citations
19.
Cervelle, Bernard, et al.. (1971). Dosage rapide du magn�sium dans les ilm�nites par micror�flectom�trie. Mineralium Deposita. 6(1). 4 indexed citations
20.
Lévy, Catherine. (1969). Badiou A., Le concept de modèle. Introduction à une épistemologie matérialiste des mathématiques.. Persée (Ministère de lEnseignement supérieur et de la Recherche).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tracee L. McMiller Breakdown of academic impact, for papers by Arabella Young Breakdown of academic impact, for papers by Yuru Meng Breakdown of academic impact, for papers by Ursina Teitelbaum Breakdown of academic impact, for papers by Elizabeth Stankevich Breakdown of academic impact, for papers by Geoffrey D. Young Breakdown of academic impact, for papers by Kazuaki Chikamatsu Breakdown of academic impact, for papers by Philip Z. Brohawn Breakdown of academic impact, for papers by Eva Karamitopoulou Breakdown of academic impact, for papers by Ester Fonsatti
Rankless by CCL
2026